Correlation Between Arcus Biosciences and AC Immune

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and AC Immune, you can compare the effects of market volatilities on Arcus Biosciences and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and AC Immune.

Diversification Opportunities for Arcus Biosciences and AC Immune

-0.17

Correlation Coefficient

Arcus Biosciences  AC Immune

Good diversification

The 3 months correlation between Arcus and ACIU is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and AC Immune go up and down completely randomly.

Pair Corralation between Arcus Biosciences and AC Immune

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 1.31 times less return on investment than AC Immune. But when comparing it to its historical volatility, Arcus Biosciences is 1.29 times less risky than AC Immune. It trades about 0.02 of its potential returns per unit of risk. AC Immune is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  269.00  in AC Immune on September 24, 2024 and sell it today you would lose (1.00) from holding AC Immune or give up 0.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arcus Biosciences  vs.  AC Immune

Arcus Biosciences

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arcus Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

AC Immune

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AC Immune has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Arcus Biosciences and AC Immune

The main advantage of trading using opposite Arcus Biosciences and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.

The idea behind Arcus Biosciences and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.